Have a Great medtech idea?
Big MedTech isn’t interested… yet.
BUT WE’RE INTERESTED.
We’ve worked for Big MedTech and, generally speaking, we’ve learned that innovation is not something Big MedTech does, rather, innovation is something Big MedTech buys. Why? Because innovation is very risky. For every successful medtech product, far more fail prior to commercialization. Therefore, rather than taking the risk of innovation upon themselves, it is far less risky for Big MedTech to purchase medtech startups when their product is beginning to show commercial potential. By the time Big MedTech steps in, the bulk of the risk has been shouldered and mitigated by the flexible, agile, efficient, lean, and hungry medtech startup.
For a host of reasons, your great medtech idea has a long, arduous, and risk-laden road ahead before it will begin to show a hint of commercial viability and potential and, thereby, compete with and catch the interest of Big MedTech.
You don’t know where to start?
We know how that feels. That’s why we’ve built a multidisciplinary team!
You don’t have the time it takes?
We also know how that feels. Recall that we are healthcare providers too!
Consult Shiphrah Biomedical Inc.
We can help you navigate the medtech road from idea to market.